1. Home
  2. ACNT vs PYPD Comparison

ACNT vs PYPD Comparison

Compare ACNT & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Industries Co.

ACNT

Ascent Industries Co.

N/A

Current Price

$13.81

Market Cap

121.5M

Sector

Industrials

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$5.41

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACNT
PYPD
Founded
1945
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Steel/Iron Ore
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.5M
107.0M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
ACNT
PYPD
Price
$13.81
$5.41
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $11.40
AVG Volume (30 Days)
18.2K
★ 112.1K
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 106.72
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.96
$3.50
52 Week High
$17.92
$5.84

Technical Indicators

Market Signals
Indicator
ACNT
PYPD
Relative Strength Index (RSI) 41.60 57.46
Support Level $13.53 $4.18
Resistance Level $14.50 $5.58
Average True Range (ATR) 0.30 0.27
MACD 0.05 0.07
Stochastic Oscillator 33.97 71.14

Price Performance

Historical Comparison
ACNT
PYPD

About ACNT Ascent Industries Co.

Ascent Industries Co is a specialty chemicals company focused on the development, production, and distribution of tailored, performance-driven chemical solutions. Its customers are spread across energy, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), agriculture, water treatment, pulp and paper, construction, automotive, and other industrial markets. The company's core product portfolio includes surfactants, defoamers, lubricating agents, flame retardants, and specialty intermediates, offered in both petroleum-based and bio-based formulations. Geographically, it generates maximum revenue from the United States, followed by Mexico, Canada, Honduras, Colombia, the Netherlands, Costa Rica, Japan, and other markets.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: